Diagnosis and Management of Novel Influenza A (H1N1).

Wie, Seong Heon; Kim, Woo Joo

doi:2009.30.11.843

Korean J Fam Med > Volume 30(11); 2009 > Article

Review

Korean Journal of Family Medicine 2009;30(11):843-847.
DOI: https://doi.org/10.4082/kjfm.2009.30.11.843 Published online November 20, 2009.

Diagnosis and Management of Novel Influenza A (H1N1).

Seong Heon Wie, Woo Joo Kim

¹Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
²Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. wjkim@korea.ac.kr

신종 인플루엔자 A (H1N1)의 진단과 치료

위성헌, 김우주

^¹
^²

Abstract

Since the World Health Organization has offi cially declared a global infl uenza pandemic, the number of human cases of pandemic infl uenza A (H1N1) in 2009 has been increasing in many countries. Especially from mid-October, the number of domestic cases of infl uenza A (H1N1) has been exponentially increasing, with the number of confi rmed cases reaching over 100,000. The clinical symptoms of novel infl uenza A (H1N1) include fever, cough, sore throat, runny nose, myalgia, headache, chills and fatigue. Nucleic acid amplification tests, including real time RT-PCR assay specific for 2009 novel influenza A (H1N1) can be used in the patients with suspected influenza. Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended by Centers for Disease Control and Prevention for treatment of novel influenza A (H1N1) disease. Personal and public efforts to control the outbreak of novel influenza A (H1N1) disease are required. Vaccination against pandemic H1N1 is important for personal health, but also to build community-level immunity to novel infl uenza A.

Key Words: Novel Infl uenza A (H1N1); Oseltamivir; Zanamivir